Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.2 SEK | 0.00% | +13.61% | +24.19% |
05-08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
04-17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.19% | 61.17M | |
+6.97% | 71.94B | |
-10.86% | 5.13B | |
+46.43% | 4.66B | |
+5.38% | 3.97B | |
-16.20% | 2.55B | |
+21.10% | 2.41B | |
-26.20% | 2.36B | |
+19.92% | 2.21B | |
+8.15% | 1.71B |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB
- Transcript : Orexo AB, 2023 Earnings Call, Feb 08, 2024